Mrowietz U, Elder J, Barker J
The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients
ARCHIVES OF DERMATOLOGICAL RESEARCH eFIRST date: 5 OCT 2006

Schaefer O, Baumann T, Treier M, et al.
Diagnostic imaging of inflammatory and tumorous diseases of the colon
RADIOLOGE 46 (8): 703-719 AUG 2006

Bizzarri C, Beccari AR, Bertini R, et al.
ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets
PHARMACOLOGY & THERAPEUTICS 112 (1): 139-149 OCT 2006

Braun J, Sieper J
Early diagnosis of spondyloarthritis
NATURE CLINICAL PRACTICE RHEUMATOLOGY 2 (10): 536-545 OCT 2006

Green C, Elliott L, Beaudoin C, et al.
A population-based ecologic study of inflammatory bowel disease: Searching for etiologic clues
AMERICAN JOURNAL OF EPIDEMIOLOGY 164 (7): 615-623 OCT 1 2006

Yamaner S, Akyuz M, Bugra D
Massive lower gastro-intestinal bleeding due to small bowel diverticula. A report of two cases
ACTA CHIRURGICA BELGICA 106 (4): 427-429 AUG 2006

Van NN, Taglinger K, Helps CR, et al.
Measurement of cytokine mRNA expression in intestinal biopsies of cats with inflammatory enteropathy using quantitative real-time RT-PCR
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY 113 (3-4): 404-414 OCT 15 2006

Moneret-Vautrin DA
Is the seric eosinophil cationic protein level a valuable tool of diagnosis in clinical practice?
REVUE DE MEDECINE INTERNE 27 (9): 679-683 SEP 2006

Kaneider NC, Leger AJ, Kuliopulos A
Therapeutic targeting of molecules involved in leukocyte-endothelial cell interactions
FEBS JOURNAL 273 (19): 4416-4424 OCT 2006

Padovan M, Castellino G, Govoni M, et al.
The treatment of the rheumatological manifestations of the inflammatory bowel diseases
RHEUMATOLOGY INTERNATIONAL 26 (11): 953-958 SEP 2006

Iweala OI, Nagler CR
Immune privilege in the gut: the establishment and maintenance of non-responsiveness to dietary antigens and commensal flora
IMMUNOLOGICAL REVIEWS 213: 82-100 OCT 2006

Odes S, Vardi H, Friger M, et al.
Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation
GASTROENTEROLOGY 131 (3): 719-728 SEP 2006

Yagmur E, Schnyder B, Scholten D, et al.
Elevated concentrations of fecal calprotectin in patients with liver cirrhosis
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 131 (36): 1930-1934 SEP 8 2006

Menzel K, Hausmann M, Obermeier F, et al.
Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo
CLINICAL AND EXPERIMENTAL IMMUNOLOGY 146 (1): 169-180 OCT 2006

Sands BE
New therapies for the treatment of inflammatory bowel disease
SURGICAL CLINICS OF NORTH AMERICA 86 (4): 1045+ AUG 2006

Tang LY, Rawsthorne P, Bernstein CN
Are perineal and luminal fistulas associated in Crohn's disease? A population-based study
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 4 (9): 1130-1134 SEP 2006

Franzke A, Hunger JK, Dittmar KEJ, et al.
Regulatory T-cells in the control of immunological diseases
ANNALS OF HEMATOLOGY 85 (11): 747-758 NOV 2006

Kolios G, Manousou P, Bourikas L, et al.
Ciprofloxacin inhibits cytokine-induced nitric oxide production in human colonic epithelium
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 36 (10): 720-729 OCT 2006

Yuki T, Ishihara S, Rumi MAK, et al.
Increased expression of midkine in the rat colon during healing of experimental colitis
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY 291 (4): G735-G743 OCT 2006

Hoeffel C, Crema MD, Belkacem A, et al.
Multi-detector row CT: Spectrum of diseases involving the ileocecal area
RADIOGRAPHICS 26 (5): 1373-1390 SEP-OCT 2006

Ziring D, Wei B, Velazquez P, et al.
Formation of B and T cell subsets require the cannabinoid receptor CB2
IMMUNOGENETICS 58 (9): 714-725 SEP 2006

Estall JL, Drucker DJ
Glucagon-like peptide-2
ANNUAL REVIEW OF NUTRITION 26: 391-411 2006

Amundsen SS, Vatn M, Wijmenga C, et al.
Association analysis of MYO9B gene polymorphisms and inflammatory bowel disease in a Norwegian cohort
TISSUE ANTIGENS 68 (3): 249-252 SEP 2006

Woodruff TM, Crane JW, Proctor LM, et al.
Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration
FASEB JOURNAL 20 (9): 1407-1417 JUL 2006

Menezes JS, Andrade MC, Senra B, et al.
Immunological activities are modulated by enteral administration of an elemental diet in mice
CLINICAL NUTRITION 25 (4): 643-652 AUG 2006

Fitzpatrick LR, Khare V, Small JS, et al.
Dextran sulfate sodium-induced colitis is associated with enhanced low molecular mass polypeptide 2 (LMP2) expression and is attenuated in LMP2 knockout mice
DIGESTIVE DISEASES AND SCIENCES 51 (7): 1269-1276 JUL 2006

McGonagle D, McDermott MF
A proposed classification of the immunological diseases - art. no. e297
PLOS MEDICINE 3 (8): 1242-1248 AUG 2006

Mao Y, Ren JA, Li JS
Regulated spatial distribution of cyclooxygenases and lipoxygenases in Crohn's ulcer - art. no. 89581
MEDIATORS OF INFLAMMATION 89581-89581 2006

Meissner PE, Jappe U, Niemeyer CM, et al.
KLINISCHE PADIATRIE eFIRST date: 15 SEP 2006

Leblond J, Hubert-Buron A, Bole-Feysot C, et al.
Regulation of proteolysis by cytokines in the human intestinal epithelial cell line HCT-8: role of IFN gamma
BIOCHIMIE 88 (7): 759-765 JUL 2006

Danese S, Fiocchi C
Etiopathogenesis of inflammatory bowel diseases
WORLD JOURNAL OF GASTROENTEROLOGY 12 (30): 4807-4812 AUG 14 2006

Pena AS
Contribution of genetics to a new vision in the understanding of inflammatory bowel disease
WORLD JOURNAL OF GASTROENTEROLOGY 12 (30): 4784-4787 AUG 14 2006

Rothfuss KS, Stange EF, Henrlinger KR
Extraintestinal manifestations and complications in inflammatory bowel diseases
WORLD JOURNAL OF GASTROENTEROLOGY 12 (30): 4819-4831 AUG 14 2006

Chapman TM, Plosker GL, Figgitt DP
VSL#3 probiotic mixture - A review of its use in chronic inflammatory bowel diseases
DRUGS 66 (10): 1371-1387 2006

Malamut G, Cabane C, Dubuquoy L, et al.
No evidence for an involvement of the p38 and JNK mitogen-activated protein in inflammatory bowel diseases
DIGESTIVE DISEASES AND SCIENCES 51 (8): 1443-1453 AUG 2006

Vizoso FJ, Gonzalez LO, Corte MD, et al.
Collagenase-3 (MMP-13) expression by inflamed mucosa in inflammatory bowel disease
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 41 (9): 1050-1055 SEP 2006

Neurath MF, Finotto S
The many roads to inflammatory bowel diseases
IMMUNITY 25 (2): 189-191 AUG 2006

Stark R, Konig HH, Leidl R
Costs of inflammatory bowel disease in Germany
PHARMACOECONOMICS 24 (8): 797-814 2006

Giampaolo B, Giuseppe P, Michele B, et al.
Treatment of active steroid-refractory inflammatory bowel diseases with granulocytapheresis: Our experience with a prospective study
WORLD JOURNAL OF GASTROENTEROLOGY 12 (14): 2201-2204 APR 14 2006

Harris G, KuoLee R, Chen WX
Role of Toll-like receptors in health and diseases of gastrointestinal tract
WORLD JOURNAL OF GASTROENTEROLOGY 12 (14): 2149-2160 APR 14 2006

Annese V, Valvano MR, Palmieri O, et al.
Multidrug resistance 1 gene in inflammatory bowel disease: A meta-analysis
WORLD JOURNAL OF GASTROENTEROLOGY 12 (23): 3636-3644 JUN 21 2006

Friedrichs F, Stoll M
Role of discs large homolog 5
WORLD JOURNAL OF GASTROENTEROLOGY 12 (23): 3651-3656 JUN 21 2006

Halme L, Paavola-Sakki P, Turunen U, et al.
Family and twin studies in inflammatory bowel disease
WORLD JOURNAL OF GASTROENTEROLOGY 12 (23): 3668-3672 JUN 21 2006

Cavanaugh J
NOD2: Ethnic and geographic differences
WORLD JOURNAL OF GASTROENTEROLOGY 12 (23): 3673-3677 JUN 21 2006

Pierik M, Rutgeerts P, Vlietinck R, et al.
Pharmacogenetics in inflammatory bowel disease
WORLD JOURNAL OF GASTROENTEROLOGY 12 (23): 3657-3667 JUN 21 2006